| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
4,043 |
3,834 |
$66K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,326 |
1,223 |
$56K |
| 80061 |
Lipid panel |
4,054 |
3,853 |
$53K |
| 80053 |
Comprehensive metabolic panel |
4,636 |
4,371 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,625 |
5,245 |
$43K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,493 |
1,364 |
$36K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
866 |
814 |
$24K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,150 |
2,053 |
$21K |
| 81000 |
|
4,876 |
4,600 |
$15K |
| 82274 |
|
882 |
826 |
$14K |
| 86701 |
|
1,016 |
967 |
$9K |
| 86328 |
|
384 |
368 |
$7K |
| 84436 |
|
807 |
767 |
$6K |
| 82043 |
|
937 |
886 |
$6K |
| 84479 |
|
805 |
767 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
618 |
594 |
$5K |
| 84153 |
|
261 |
243 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
358 |
176 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
80 |
78 |
$3K |
| 86738 |
|
171 |
166 |
$3K |
| 87088 |
|
277 |
271 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
51 |
49 |
$2K |
| 86329 |
|
158 |
153 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
265 |
259 |
$2K |
| 86592 |
|
345 |
336 |
$1K |
| 84439 |
|
119 |
118 |
$1K |
| 82607 |
|
72 |
69 |
$1K |
| 82570 |
|
73 |
70 |
$401.06 |
| 86803 |
|
26 |
26 |
$395.35 |
| 87185 |
|
67 |
65 |
$347.06 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
259 |
231 |
$0.18 |